Immune effectors are thought to assist tumor growth; immunosuppressive regulatory T cells are associated with reduced survival, and the balance of the T cell subsets (regulated by NF-κB) has been shown to be critical to disease outcome [15]. This evidence concerns the gene NFKB1 and neoplasm.